カテゴリー： 世界, 医療/バイオ, LP Information

世界の抗破傷風血清市場予測 2023年-2029年

【英語タイトル】Global Antitetanus Serum Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02553）・商品コード：LP23DC02553
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：109
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥549,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥823,500見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,098,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の抗破傷風血清市場」は、過去の販売実績から2022年の世界の抗破傷風血清の総販売量を検討し、2023年から2029年の予測される抗破傷風血清の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の抗破傷風血清の市場規模を掲載し、XXX百万米ドル規模の世界の抗破傷風血清市場の詳細な分析を提供します。本インサイトレポートは、世界の抗破傷風血清業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の抗破傷風血清市場における各社の独自のポジションをより深く理解するために、抗破傷風血清製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の抗破傷風血清市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。抗破傷風血清の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。抗破傷風血清の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。抗破傷風血清のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

抗破傷風血清の世界主要メーカーとしては、Haffkine Ajintha Pharmaceuticals、 jsbiology、 Grifols、 Jiangxi Institute of Biological Products、 HAFFKINE BIO-PHARMACEUTICAL、 Serum Institute of India、 Biological Products、 Bharat Serums and Vaccines、 National Institutes of Health、 Premium Serums、 Venkat Pharma、 LEXICARE PHARMAなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の抗破傷風血清市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では抗破傷風血清市場をセグメンテーションし、種類別 (動物血清、ヒト血清)、用途別 (診療所、病院)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：動物血清、ヒト血清

・用途別区分：診療所、病院

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の抗破傷風血清市場の10年間の市場状況・展望は？
・世界および地域別に見た抗破傷風血清市場成長の要因は何か？
・抗破傷風血清の市場機会はエンドマーケットの規模によってどのように変化するのか？
・抗破傷風血清のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：抗破傷風血清の年間販売量2018-2029、地域別現状・将来分析
・抗破傷風血清の種類別セグメント：動物血清、ヒト血清
・抗破傷風血清の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・抗破傷風血清の用途別セグメント：診療所、病院
・抗破傷風血清の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の抗破傷風血清市場
・企業別のグローバル抗破傷風血清市場データ：2018-2023年の年間販売量、市場シェア
・企業別の抗破傷風血清の年間売上：2018-2023年の売上、市場シェア
・企業別の抗破傷風血清販売価格
・主要企業の抗破傷風血清生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

抗破傷風血清の地域別レビュー
・地域別の抗破傷風血清市場規模2018-2023：年間販売量、売上
・主要国別の抗破傷風血清市場規模2018-2023：年間販売量、売上
・南北アメリカの抗破傷風血清販売の成長
・アジア太平洋の抗破傷風血清販売の成長
・ヨーロッパの抗破傷風血清販売の成長
・中東・アフリカの抗破傷風血清販売の成長

南北アメリカ市場
・南北アメリカの国別の抗破傷風血清販売量、売上（2018-2023）
・南北アメリカの抗破傷風血清の種類別販売量
・南北アメリカの抗破傷風血清の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の抗破傷風血清販売量、売上（2018-2023）
・アジア太平洋の抗破傷風血清の種類別販売量
・アジア太平洋の抗破傷風血清の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の抗破傷風血清販売量、売上（2018-2023）
・ヨーロッパの抗破傷風血清の種類別販売量
・ヨーロッパの抗破傷風血清の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の抗破傷風血清販売量、売上（2018-2023）
・中東・アフリカの抗破傷風血清の種類別販売量
・中東・アフリカの抗破傷風血清の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・抗破傷風血清の製造コスト構造分析
・抗破傷風血清の製造プロセス分析
・抗破傷風血清の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・抗破傷風血清の主要なグローバル販売業者
・抗破傷風血清の主要なグローバル顧客

地域別の抗破傷風血清市場予測レビュー
・地域別の抗破傷風血清市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・抗破傷風血清の種類別市場規模予測
・抗破傷風血清の用途別市場規模予測

主要企業分析
Haffkine Ajintha Pharmaceuticals、 jsbiology、 Grifols、 Jiangxi Institute of Biological Products、 HAFFKINE BIO-PHARMACEUTICAL、 Serum Institute of India、 Biological Products、 Bharat Serums and Vaccines、 National Institutes of Health、 Premium Serums、 Venkat Pharma、 LEXICARE PHARMA
・企業情報
・抗破傷風血清製品
・抗破傷風血清販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Antitetanus Serum market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Antitetanus Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Antitetanus Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Antitetanus Serum is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Antitetanus Serum players cover Haffkine Ajintha Pharmaceuticals, jsbiology, Grifols, Jiangxi Institute of Biological Products, HAFFKINE BIO-PHARMACEUTICAL, Serum Institute of India, Biological Products, Bharat Serums and Vaccines and National Institutes of Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Antitetanus Serum Industry Forecast” looks at past sales and reviews total world Antitetanus Serum sales in 2022, providing a comprehensive analysis by region and market sector of projected Antitetanus Serum sales for 2023 through 2029. With Antitetanus Serum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antitetanus Serum industry.
This Insight Report provides a comprehensive analysis of the global Antitetanus Serum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antitetanus Serum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antitetanus Serum market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antitetanus Serum and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antitetanus Serum.
This report presents a comprehensive overview, market shares, and growth opportunities of Antitetanus Serum market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Animal Serum
Human Serum
Segmentation by application
Clinic
Hospital
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Haffkine Ajintha Pharmaceuticals
jsbiology
Grifols
Jiangxi Institute of Biological Products
HAFFKINE BIO-PHARMACEUTICAL
Serum Institute of India
Biological Products
Bharat Serums and Vaccines
National Institutes of Health
Premium Serums
Venkat Pharma
LEXICARE PHARMA
Key Questions Addressed in this Report
What is the 10-year outlook for the global Antitetanus Serum market?
What factors are driving Antitetanus Serum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Antitetanus Serum market opportunities vary by end market size?
How does Antitetanus Serum break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antitetanus Serum Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Antitetanus Serum by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Antitetanus Serum by Country/Region, 2018, 2022 & 2029
2.2 Antitetanus Serum Segment by Type
2.2.1 Animal Serum
2.2.2 Human Serum
2.3 Antitetanus Serum Sales by Type
2.3.1 Global Antitetanus Serum Sales Market Share by Type (2018-2023)
2.3.2 Global Antitetanus Serum Revenue and Market Share by Type (2018-2023)
2.3.3 Global Antitetanus Serum Sale Price by Type (2018-2023)
2.4 Antitetanus Serum Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.5 Antitetanus Serum Sales by Application
2.5.1 Global Antitetanus Serum Sale Market Share by Application (2018-2023)
2.5.2 Global Antitetanus Serum Revenue and Market Share by Application (2018-2023)
2.5.3 Global Antitetanus Serum Sale Price by Application (2018-2023)
3 Global Antitetanus Serum by Company
3.1 Global Antitetanus Serum Breakdown Data by Company
3.1.1 Global Antitetanus Serum Annual Sales by Company (2018-2023)
3.1.2 Global Antitetanus Serum Sales Market Share by Company (2018-2023)
3.2 Global Antitetanus Serum Annual Revenue by Company (2018-2023)
3.2.1 Global Antitetanus Serum Revenue by Company (2018-2023)
3.2.2 Global Antitetanus Serum Revenue Market Share by Company (2018-2023)
3.3 Global Antitetanus Serum Sale Price by Company
3.4 Key Manufacturers Antitetanus Serum Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Antitetanus Serum Product Location Distribution
3.4.2 Players Antitetanus Serum Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Antitetanus Serum by Geographic Region
4.1 World Historic Antitetanus Serum Market Size by Geographic Region (2018-2023)
4.1.1 Global Antitetanus Serum Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Antitetanus Serum Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Antitetanus Serum Market Size by Country/Region (2018-2023)
4.2.1 Global Antitetanus Serum Annual Sales by Country/Region (2018-2023)
4.2.2 Global Antitetanus Serum Annual Revenue by Country/Region (2018-2023)
4.3 Americas Antitetanus Serum Sales Growth
4.4 APAC Antitetanus Serum Sales Growth
4.5 Europe Antitetanus Serum Sales Growth
4.6 Middle East & Africa Antitetanus Serum Sales Growth
5 Americas
5.1 Americas Antitetanus Serum Sales by Country
5.1.1 Americas Antitetanus Serum Sales by Country (2018-2023)
5.1.2 Americas Antitetanus Serum Revenue by Country (2018-2023)
5.2 Americas Antitetanus Serum Sales by Type
5.3 Americas Antitetanus Serum Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Antitetanus Serum Sales by Region
6.1.1 APAC Antitetanus Serum Sales by Region (2018-2023)
6.1.2 APAC Antitetanus Serum Revenue by Region (2018-2023)
6.2 APAC Antitetanus Serum Sales by Type
6.3 APAC Antitetanus Serum Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Antitetanus Serum by Country
7.1.1 Europe Antitetanus Serum Sales by Country (2018-2023)
7.1.2 Europe Antitetanus Serum Revenue by Country (2018-2023)
7.2 Europe Antitetanus Serum Sales by Type
7.3 Europe Antitetanus Serum Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Antitetanus Serum by Country
8.1.1 Middle East & Africa Antitetanus Serum Sales by Country (2018-2023)
8.1.2 Middle East & Africa Antitetanus Serum Revenue by Country (2018-2023)
8.2 Middle East & Africa Antitetanus Serum Sales by Type
8.3 Middle East & Africa Antitetanus Serum Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antitetanus Serum
10.3 Manufacturing Process Analysis of Antitetanus Serum
10.4 Industry Chain Structure of Antitetanus Serum
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Antitetanus Serum Distributors
11.3 Antitetanus Serum Customer
12 World Forecast Review for Antitetanus Serum by Geographic Region
12.1 Global Antitetanus Serum Market Size Forecast by Region
12.1.1 Global Antitetanus Serum Forecast by Region (2024-2029)
12.1.2 Global Antitetanus Serum Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antitetanus Serum Forecast by Type
12.7 Global Antitetanus Serum Forecast by Application
13 Key Players Analysis
13.1 Haffkine Ajintha Pharmaceuticals
13.1.1 Haffkine Ajintha Pharmaceuticals Company Information
13.1.2 Haffkine Ajintha Pharmaceuticals Antitetanus Serum Product Portfolios and Specifications
13.1.3 Haffkine Ajintha Pharmaceuticals Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Haffkine Ajintha Pharmaceuticals Main Business Overview
13.1.5 Haffkine Ajintha Pharmaceuticals Latest Developments
13.2 jsbiology
13.2.1 jsbiology Company Information
13.2.2 jsbiology Antitetanus Serum Product Portfolios and Specifications
13.2.3 jsbiology Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 jsbiology Main Business Overview
13.2.5 jsbiology Latest Developments
13.3 Grifols
13.3.1 Grifols Company Information
13.3.2 Grifols Antitetanus Serum Product Portfolios and Specifications
13.3.3 Grifols Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Grifols Main Business Overview
13.3.5 Grifols Latest Developments
13.4 Jiangxi Institute of Biological Products
13.4.1 Jiangxi Institute of Biological Products Company Information
13.4.2 Jiangxi Institute of Biological Products Antitetanus Serum Product Portfolios and Specifications
13.4.3 Jiangxi Institute of Biological Products Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Jiangxi Institute of Biological Products Main Business Overview
13.4.5 Jiangxi Institute of Biological Products Latest Developments
13.5 HAFFKINE BIO-PHARMACEUTICAL
13.5.1 HAFFKINE BIO-PHARMACEUTICAL Company Information
13.5.2 HAFFKINE BIO-PHARMACEUTICAL Antitetanus Serum Product Portfolios and Specifications
13.5.3 HAFFKINE BIO-PHARMACEUTICAL Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 HAFFKINE BIO-PHARMACEUTICAL Main Business Overview
13.5.5 HAFFKINE BIO-PHARMACEUTICAL Latest Developments
13.6 Serum Institute of India
13.6.1 Serum Institute of India Company Information
13.6.2 Serum Institute of India Antitetanus Serum Product Portfolios and Specifications
13.6.3 Serum Institute of India Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Serum Institute of India Main Business Overview
13.6.5 Serum Institute of India Latest Developments
13.7 Biological Products
13.7.1 Biological Products Company Information
13.7.2 Biological Products Antitetanus Serum Product Portfolios and Specifications
13.7.3 Biological Products Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biological Products Main Business Overview
13.7.5 Biological Products Latest Developments
13.8 Bharat Serums and Vaccines
13.8.1 Bharat Serums and Vaccines Company Information
13.8.2 Bharat Serums and Vaccines Antitetanus Serum Product Portfolios and Specifications
13.8.3 Bharat Serums and Vaccines Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bharat Serums and Vaccines Main Business Overview
13.8.5 Bharat Serums and Vaccines Latest Developments
13.9 National Institutes of Health
13.9.1 National Institutes of Health Company Information
13.9.2 National Institutes of Health Antitetanus Serum Product Portfolios and Specifications
13.9.3 National Institutes of Health Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 National Institutes of Health Main Business Overview
13.9.5 National Institutes of Health Latest Developments
13.10 Premium Serums
13.10.1 Premium Serums Company Information
13.10.2 Premium Serums Antitetanus Serum Product Portfolios and Specifications
13.10.3 Premium Serums Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Premium Serums Main Business Overview
13.10.5 Premium Serums Latest Developments
13.11 Venkat Pharma
13.11.1 Venkat Pharma Company Information
13.11.2 Venkat Pharma Antitetanus Serum Product Portfolios and Specifications
13.11.3 Venkat Pharma Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Venkat Pharma Main Business Overview
13.11.5 Venkat Pharma Latest Developments
13.12 LEXICARE PHARMA
13.12.1 LEXICARE PHARMA Company Information
13.12.2 LEXICARE PHARMA Antitetanus Serum Product Portfolios and Specifications
13.12.3 LEXICARE PHARMA Antitetanus Serum Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 LEXICARE PHARMA Main Business Overview
13.12.5 LEXICARE PHARMA Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Antitetanus Serum Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Antitetanus Serum Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Animal Serum
Table 4. Major Players of Human Serum
Table 5. Global Antitetanus Serum Sales by Type (2018-2023) & (K Units)
Table 6. Global Antitetanus Serum Sales Market Share by Type (2018-2023)
Table 7. Global Antitetanus Serum Revenue by Type (2018-2023) & ($ million)
Table 8. Global Antitetanus Serum Revenue Market Share by Type (2018-2023)
Table 9. Global Antitetanus Serum Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Antitetanus Serum Sales by Application (2018-2023) & (K Units)
Table 11. Global Antitetanus Serum Sales Market Share by Application (2018-2023)
Table 12. Global Antitetanus Serum Revenue by Application (2018-2023)
Table 13. Global Antitetanus Serum Revenue Market Share by Application (2018-2023)
Table 14. Global Antitetanus Serum Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Antitetanus Serum Sales by Company (2018-2023) & (K Units)
Table 16. Global Antitetanus Serum Sales Market Share by Company (2018-2023)
Table 17. Global Antitetanus Serum Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Antitetanus Serum Revenue Market Share by Company (2018-2023)
Table 19. Global Antitetanus Serum Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Antitetanus Serum Producing Area Distribution and Sales Area
Table 21. Players Antitetanus Serum Products Offered
Table 22. Antitetanus Serum Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Antitetanus Serum Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Antitetanus Serum Sales Market Share Geographic Region (2018-2023)
Table 27. Global Antitetanus Serum Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Antitetanus Serum Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Antitetanus Serum Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Antitetanus Serum Sales Market Share by Country/Region (2018-2023)
Table 31. Global Antitetanus Serum Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Antitetanus Serum Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Antitetanus Serum Sales by Country (2018-2023) & (K Units)
Table 34. Americas Antitetanus Serum Sales Market Share by Country (2018-2023)
Table 35. Americas Antitetanus Serum Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Antitetanus Serum Revenue Market Share by Country (2018-2023)
Table 37. Americas Antitetanus Serum Sales by Type (2018-2023) & (K Units)
Table 38. Americas Antitetanus Serum Sales by Application (2018-2023) & (K Units)
Table 39. APAC Antitetanus Serum Sales by Region (2018-2023) & (K Units)
Table 40. APAC Antitetanus Serum Sales Market Share by Region (2018-2023)
Table 41. APAC Antitetanus Serum Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Antitetanus Serum Revenue Market Share by Region (2018-2023)
Table 43. APAC Antitetanus Serum Sales by Type (2018-2023) & (K Units)
Table 44. APAC Antitetanus Serum Sales by Application (2018-2023) & (K Units)
Table 45. Europe Antitetanus Serum Sales by Country (2018-2023) & (K Units)
Table 46. Europe Antitetanus Serum Sales Market Share by Country (2018-2023)
Table 47. Europe Antitetanus Serum Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Antitetanus Serum Revenue Market Share by Country (2018-2023)
Table 49. Europe Antitetanus Serum Sales by Type (2018-2023) & (K Units)
Table 50. Europe Antitetanus Serum Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Antitetanus Serum Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Antitetanus Serum Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Antitetanus Serum Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Antitetanus Serum Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Antitetanus Serum Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Antitetanus Serum Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Antitetanus Serum
Table 58. Key Market Challenges & Risks of Antitetanus Serum
Table 59. Key Industry Trends of Antitetanus Serum
Table 60. Antitetanus Serum Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Antitetanus Serum Distributors List
Table 63. Antitetanus Serum Customer List
Table 64. Global Antitetanus Serum Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Antitetanus Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Antitetanus Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Antitetanus Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Antitetanus Serum Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Antitetanus Serum Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Antitetanus Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Antitetanus Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Antitetanus Serum Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Antitetanus Serum Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Antitetanus Serum Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Antitetanus Serum Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Antitetanus Serum Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Antitetanus Serum Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Haffkine Ajintha Pharmaceuticals Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 79. Haffkine Ajintha Pharmaceuticals Antitetanus Serum Product Portfolios and Specifications
Table 80. Haffkine Ajintha Pharmaceuticals Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Haffkine Ajintha Pharmaceuticals Main Business
Table 82. Haffkine Ajintha Pharmaceuticals Latest Developments
Table 83. jsbiology Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 84. jsbiology Antitetanus Serum Product Portfolios and Specifications
Table 85. jsbiology Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. jsbiology Main Business
Table 87. jsbiology Latest Developments
Table 88. Grifols Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 89. Grifols Antitetanus Serum Product Portfolios and Specifications
Table 90. Grifols Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Grifols Main Business
Table 92. Grifols Latest Developments
Table 93. Jiangxi Institute of Biological Products Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 94. Jiangxi Institute of Biological Products Antitetanus Serum Product Portfolios and Specifications
Table 95. Jiangxi Institute of Biological Products Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Jiangxi Institute of Biological Products Main Business
Table 97. Jiangxi Institute of Biological Products Latest Developments
Table 98. HAFFKINE BIO-PHARMACEUTICAL Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 99. HAFFKINE BIO-PHARMACEUTICAL Antitetanus Serum Product Portfolios and Specifications
Table 100. HAFFKINE BIO-PHARMACEUTICAL Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. HAFFKINE BIO-PHARMACEUTICAL Main Business
Table 102. HAFFKINE BIO-PHARMACEUTICAL Latest Developments
Table 103. Serum Institute of India Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 104. Serum Institute of India Antitetanus Serum Product Portfolios and Specifications
Table 105. Serum Institute of India Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Serum Institute of India Main Business
Table 107. Serum Institute of India Latest Developments
Table 108. Biological Products Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 109. Biological Products Antitetanus Serum Product Portfolios and Specifications
Table 110. Biological Products Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Biological Products Main Business
Table 112. Biological Products Latest Developments
Table 113. Bharat Serums and Vaccines Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 114. Bharat Serums and Vaccines Antitetanus Serum Product Portfolios and Specifications
Table 115. Bharat Serums and Vaccines Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Bharat Serums and Vaccines Main Business
Table 117. Bharat Serums and Vaccines Latest Developments
Table 118. National Institutes of Health Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 119. National Institutes of Health Antitetanus Serum Product Portfolios and Specifications
Table 120. National Institutes of Health Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. National Institutes of Health Main Business
Table 122. National Institutes of Health Latest Developments
Table 123. Premium Serums Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 124. Premium Serums Antitetanus Serum Product Portfolios and Specifications
Table 125. Premium Serums Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Premium Serums Main Business
Table 127. Premium Serums Latest Developments
Table 128. Venkat Pharma Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 129. Venkat Pharma Antitetanus Serum Product Portfolios and Specifications
Table 130. Venkat Pharma Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Venkat Pharma Main Business
Table 132. Venkat Pharma Latest Developments
Table 133. LEXICARE PHARMA Basic Information, Antitetanus Serum Manufacturing Base, Sales Area and Its Competitors
Table 134. LEXICARE PHARMA Antitetanus Serum Product Portfolios and Specifications
Table 135. LEXICARE PHARMA Antitetanus Serum Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. LEXICARE PHARMA Main Business
Table 137. LEXICARE PHARMA Latest Developments
List of Figures
Figure 1. Picture of Antitetanus Serum
Figure 2. Antitetanus Serum Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antitetanus Serum Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Antitetanus Serum Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Antitetanus Serum Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Animal Serum
Figure 10. Product Picture of Human Serum
Figure 11. Global Antitetanus Serum Sales Market Share by Type in 2022
Figure 12. Global Antitetanus Serum Revenue Market Share by Type (2018-2023)
Figure 13. Antitetanus Serum Consumed in Clinic
Figure 14. Global Antitetanus Serum Market: Clinic (2018-2023) & (K Units)
Figure 15. Antitetanus Serum Consumed in Hospital
Figure 16. Global Antitetanus Serum Market: Hospital (2018-2023) & (K Units)
Figure 17. Global Antitetanus Serum Sales Market Share by Application (2022)
Figure 18. Global Antitetanus Serum Revenue Market Share by Application in 2022
Figure 19. Antitetanus Serum Sales Market by Company in 2022 (K Units)
Figure 20. Global Antitetanus Serum Sales Market Share by Company in 2022
Figure 21. Antitetanus Serum Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Antitetanus Serum Revenue Market Share by Company in 2022
Figure 23. Global Antitetanus Serum Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Antitetanus Serum Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Antitetanus Serum Sales 2018-2023 (K Units)
Figure 26. Americas Antitetanus Serum Revenue 2018-2023 ($ Millions)
Figure 27. APAC Antitetanus Serum Sales 2018-2023 (K Units)
Figure 28. APAC Antitetanus Serum Revenue 2018-2023 ($ Millions)
Figure 29. Europe Antitetanus Serum Sales 2018-2023 (K Units)
Figure 30. Europe Antitetanus Serum Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Antitetanus Serum Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Antitetanus Serum Revenue 2018-2023 ($ Millions)
Figure 33. Americas Antitetanus Serum Sales Market Share by Country in 2022
Figure 34. Americas Antitetanus Serum Revenue Market Share by Country in 2022
Figure 35. Americas Antitetanus Serum Sales Market Share by Type (2018-2023)
Figure 36. Americas Antitetanus Serum Sales Market Share by Application (2018-2023)
Figure 37. United States Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Antitetanus Serum Sales Market Share by Region in 2022
Figure 42. APAC Antitetanus Serum Revenue Market Share by Regions in 2022
Figure 43. APAC Antitetanus Serum Sales Market Share by Type (2018-2023)
Figure 44. APAC Antitetanus Serum Sales Market Share by Application (2018-2023)
Figure 45. China Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Antitetanus Serum Sales Market Share by Country in 2022
Figure 53. Europe Antitetanus Serum Revenue Market Share by Country in 2022
Figure 54. Europe Antitetanus Serum Sales Market Share by Type (2018-2023)
Figure 55. Europe Antitetanus Serum Sales Market Share by Application (2018-2023)
Figure 56. Germany Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Antitetanus Serum Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Antitetanus Serum Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Antitetanus Serum Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Antitetanus Serum Sales Market Share by Application (2018-2023)
Figure 65. Egypt Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Antitetanus Serum Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Antitetanus Serum in 2022
Figure 71. Manufacturing Process Analysis of Antitetanus Serum
Figure 72. Industry Chain Structure of Antitetanus Serum
Figure 73. Channels of Distribution
Figure 74. Global Antitetanus Serum Sales Market Forecast by Region (2024-2029)
Figure 75. Global Antitetanus Serum Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Antitetanus Serum Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Antitetanus Serum Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Antitetanus Serum Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Antitetanus Serum Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の抗破傷風血清市場予測 2023年-2029年] (コード：LP23DC02553)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の抗破傷風血清市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の抗狂犬病血清市場予測 2023年-2029年
  • 世界の組換えヒト血清アルブミン市場予測 2023年-2029年
  • 世界の動物血清製品市場予測 2023年-2029年
  • 世界の経口ワクチン投与市場予測 2023年-2029年
  • 世界の経口投与ワクチン市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆